Falasca, Marco
Università di Parma,
Italy
2025 Rank: 71496
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1146 out of 212967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71496 | 75751 |
| Total Cites | 1009 | 1281 |
| H-index | 12 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 54 | 58 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 430 | 462 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 946 | 1194 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
21.23%
|
|
Falasca, Marco
Università di Parma,
Italy
2024 Rank: 58553
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1051 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58553 | 66465 |
| Total Cites | 747 | 788 |
| H-index | 13 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 68 | 71 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 471 | 493 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 636 | 657 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.20 |
| Self-Citation Percentage |
5.20%
|
|
Falasca, Marco
Curtin Medical School,
Australia
2023 Rank: 73527
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1487 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73527 | 72194 |
| Total Cites | 776 | 856 |
| H-index | 12 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 67 | 74 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 502 | 542 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 700 | 727 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.18 |
| Self-Citation Percentage |
9.35%
|
|
Falasca, Marco
Curtin Medical School,
Australia
2022 Rank: 57286
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1347 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57286 | 61207 |
| Total Cites | 792 | 853 |
| H-index | 14 | 15 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 74 | 79 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 523 | 556 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 681 | 712 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
7.15%
|
|
Falasca, Marco
Curtin Medical School,
Australia
2021 Rank: 44923
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1026 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44923 | 47881 |
| Total Cites | 1029 | 1134 |
| H-index | 16 | 17 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 124 | 135 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 734 | 787 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 882 | 919 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
9.26%
|
|
Falasca, Marco
Curtin University,
Australia
2020 Rank: 83536
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1629 out of 135836 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83536 | 74482 |
| Total Cites | 604 | 722 |
| H-index | 12 | 12 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 3 | 5 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 98 | 118 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 403 | 473 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 512 | 543 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.33 |
| Self-Citation Percentage |
16.34%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.